Post marketing safety surveillance of atezolizumab based on a retrospective analysis of the FDA adverse events reporting system (FAERS).
Saved in:
| Title: | Post marketing safety surveillance of atezolizumab based on a retrospective analysis of the FDA adverse events reporting system (FAERS). |
|---|---|
| Authors: | Zhang, Gan1,2 (AUTHOR), Yu, Danfeng3 (AUTHOR), Pan, Huan4 (AUTHOR), Liu, Jiong1,2 (AUTHOR), Wang, Ruling1,2 (AUTHOR), Wan, Yunyan1,2 (AUTHOR), Zhou, Wuhua1,2 (AUTHOR) ministerwuhua@163.com, Wang, Huaxiang1,2 (AUTHOR) whx@taihehospital.com |
| Source: | Scientific Reports. 11/26/2025, Vol. 15 Issue 1, p1-12. 12p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
